Kyverna Therapeutics Inc. (KYTX)
undefined
undefined%
At close: undefined

Ratios (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21
PE Ratio -83.69 -6.70 -7.34
PS Ratio 0.00 27.55 34.22
PB Ratio 102.73 -2.62 -4.18
P/FCF Ratio -95.27 -5.25 -8.25
P/OCF Ratio -96.40 -5.36 -8.74
OCF/S Ratio 0.00 -1.29 -0.98
Debt / Equity Ratio 0.01 0.00 0.00
Quick Ratio 0.76 1.11 1.21
Current Ratio 0.76 1.11 1.21
Asset Turnover 0.00 0.10 0.07
Interest Coverage -83.43 -113.02 -2195.50
Return on Equity (ROE) -122.75% 39.05% 56.97%
Return on Assets (ROA) -80.28%-43.17%-30.82%
Return on Capital (ROIC) -112.78%-53.45%-37.88%
Dividend Yield 0.00%0.00%0.00%
Payout Ratio 0.00% 0.00% 0.00%
Gross Profit Margin 0.00% 21.26% 22.41%
Net Profit Margin 0.00% -102.82% -116.47%